Stay updated with breaking news from American headache. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr Nathaniel Schuster from UC San Diego and colleagues tested a cannabis product with 6% THC based on prior studies showing efficacy of that concentration for other pain conditions. ....
Migraine attacks often become less frequent and less severe after 60. For those who still need treatment, the newer medications may be safer options. ....
Long-term benefits of Vyepti® confirmed by new data presented at the annual meeting of the American Headache SocietyAn extension phase of the DELIVER study with Vyepti® (eptinezumab) demonstrated long-lasting migraine preventive effects with treatment for up to 18 months, reducing both frequency and severity. ....
This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used. ....
DailyMail.com spoke to with neurologists who specialize in treating headaches to highlight some common yet surprising triggers of migraines - suffered by 40million Americans. ....